A. A. Antonov
A. A. Antonov has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Filipp V. Gorkavenko
Center for Healthcare Quality Assessment and Control; Sechenov University; Russian Medical Academy of Continuing Professional Education
1 shared publication G. N. Salogub
V.A. Almazov National Medical Research Centre, Ministry of Health of Russia
1 shared publication- Iu. S. Osipov
VA Almazov National Medical Research Center, 2 Akkuratova ul., Saint Petersburg, Russian Federation, 197341
1 shared publication - Nuriya Zagitovna Musina
Sechenov University
1 shared publication - Valeriya Aleksandrovna Lemeshko
Moscow Institute of Physics and Technology
1 shared publication - Vitaliy Vladimirovich Omelyanovskiy
Center for Healthcare Quality Assessment and Control; Russian Medical Academy of Continuing Professional Education
1 shared publication
Latest Publications
- Open Access
- 22 May 2025
- Published by Publishing House ABV Press in Oncohematology
- Vol. 20 (2) , 126-137
Invasive aspergillosis in patients with acute myeloid leukemia: difficulties in choosing first-line therapy in real clinical practice and pharmacoeconomic analysis of the feasibility of using new antifungal drugs
The article discusses the epidemiology and difficulties of diagnosing invasive aspergillosis in patients with acute myeloid leukemia, the role of pharmacokinetic and pharmacogenetic studies in choosing the optimal treatment regimen, and an attempt at pharmacoeconomic analysis to create an optimal treatment strategy for this complication.
- 22 May 2025
- Published by Publishing House ABV Press in Oncohematology
- Vol. 20 (2) , 126-137
Open AccessInvasive aspergillosis in patients with acute myeloid leukemia: difficulties in choosing first-line therapy in real clinical practice and pharmacoeconomic analysis of the feasibility of using new antifungal drugs
The article discusses the epidemiology and difficulties of diagnosing invasive aspergillosis in patients with acute myeloid leukemia, the role of pharmacokinetic and pharmacogenetic studies in choosing the optimal treatment regimen, and an attempt at pharmacoeconomic analysis to create an optimal treatment strategy for this complication.
- Open Access
- 9 August 2020
- Published by IRBIS in FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
- Vol. 13 (2) , 170-182
Affordability of in vivo gene therapy. Problems and potential solutions
Affordability of in vivo gene therapy. Problems and potential solutions
- 9 August 2020
- Published by IRBIS in FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
- Vol. 13 (2) , 170-182
Open AccessAffordability of in vivo gene therapy. Problems and potential solutions
Affordability of in vivo gene therapy. Problems and potential solutions